Peritoneal Cancer
Peritoneal cancer is a type of cancer that occurs in the peritoneum, the lining of the abdominal cavity, often associated with other cancers like ovarian cancer.
Advanced Ovarian Cancer: TORL-1-23 Treatment Study
We are studying the effectiveness of TORL-1-23 in women with advanced platinum-resistant ovarian cancer that expresses Claudin 6. This research aims to find new treatment options for this challenging condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Ovarian Cancer
Ovarian cancer is a type of cancer that begins in the ovaries, often causing symptoms like abdominal swelling, pain, and changes in menstrual cycles.
Fallopian Tube Cancer
Fallopian tube cancer is a rare type of cancer that starts in the fallopian tubes, which connect the ovaries to the uterus, and may present symptoms similar to ovarian cancer.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female aged 18 years or older?
- Do you have advanced (unresectable) or metastatic ovarian cancer that is resistant to platinum-containing therapy?
- Do you have measurable tumor at baseline?
- Have you had any cancer treatments in the last 14 days?
- Are you still experiencing significant side effects from previous cancer treatments?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Monoclonal Antibody
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Department of Gynecology and Obstetrics
Graz, Austria
Medizinische Universitaet Innsbruck
Department of Gynecology and Obstetrics
Innsbruck, Austria
Ordensklinikum Linz GmbH
Department of Gynecology
Linz, Austria
Sponsor: Torl Biotherapeutics LLC
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.